HCA Healthcare (NYSE:HCA) Price Target Raised to $367.00 at Barclays

HCA Healthcare (NYSE:HCA) had its price objective boosted by Barclays from $356.00 to $367.00 in a research note issued to investors on Monday morning, Benzinga reports. Barclays currently has an overweight rating on the stock.

A number of other brokerages have also recently weighed in on HCA. Raymond James upped their price target on shares of HCA Healthcare from $300.00 to $330.00 and gave the stock an outperform rating in a research report on Wednesday, January 31st. Royal Bank of Canada upped their price target on HCA Healthcare from $322.00 to $329.00 and gave the stock an outperform rating in a report on Monday. Oppenheimer upped their target price on shares of HCA Healthcare from $330.00 to $345.00 and gave the company an outperform rating in a research note on Monday. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of HCA Healthcare from $330.00 to $359.00 and gave the stock a buy rating in a report on Friday, April 12th. Finally, Truist Financial boosted their price target on HCA Healthcare from $320.00 to $345.00 and gave the stock a buy rating in a research note on Wednesday, January 31st. Four analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of Moderate Buy and a consensus target price of $316.59.

HCA Healthcare Stock Down 0.1 %

Shares of HCA opened at $309.44 on Monday. The company has a quick ratio of 1.02, a current ratio of 1.16 and a debt-to-equity ratio of 29.26. The firm has a market cap of $81.84 billion, a PE ratio of 15.43, a price-to-earnings-growth ratio of 1.48 and a beta of 1.65. The company’s fifty day moving average is $323.07 and its two-hundred day moving average is $296.64. HCA Healthcare has a fifty-two week low of $215.96 and a fifty-two week high of $335.83.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 26th. The company reported $5.36 EPS for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $16.81 billion. During the same period last year, the business posted $4.93 EPS. The company’s quarterly revenue was up 11.2% compared to the same quarter last year. Analysts forecast that HCA Healthcare will post 20.82 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.85%. The ex-dividend date of this dividend is Friday, June 14th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

HCA Healthcare declared that its Board of Directors has approved a share buyback plan on Tuesday, January 30th that authorizes the company to repurchase $6.00 billion in shares. This repurchase authorization authorizes the company to purchase up to 7.4% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s leadership believes its stock is undervalued.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Chad J. Wasserman sold 652 shares of the stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $312.04, for a total value of $203,450.08. Following the sale, the senior vice president now directly owns 290 shares of the company’s stock, valued at $90,491.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other HCA Healthcare news, SVP Chad J. Wasserman sold 652 shares of the company’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $312.04, for a total value of $203,450.08. Following the completion of the transaction, the senior vice president now owns 290 shares in the company, valued at approximately $90,491.60. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Kathleen M. Whalen sold 4,262 shares of the firm’s stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $306.21, for a total value of $1,305,067.02. Following the completion of the sale, the senior vice president now owns 10,250 shares in the company, valued at $3,138,652.50. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 7,779 shares of company stock worth $2,421,814. 1.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in HCA. Sanders Capital LLC raised its stake in shares of HCA Healthcare by 4.2% in the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after buying an additional 456,738 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of HCA Healthcare by 1.7% during the 4th quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock valued at $2,757,181,000 after purchasing an additional 170,560 shares in the last quarter. Royal Bank of Canada lifted its stake in HCA Healthcare by 35.7% during the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after purchasing an additional 1,183,890 shares during the last quarter. Norges Bank acquired a new position in HCA Healthcare in the fourth quarter worth approximately $694,985,000. Finally, Northern Trust Corp boosted its stake in shares of HCA Healthcare by 3.2% during the 3rd quarter. Northern Trust Corp now owns 2,152,419 shares of the company’s stock worth $529,452,000 after acquiring an additional 67,332 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.